Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution Analysis

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Di Rocco, Giuliana ^a   Baldari, Silvia ^a   Toietta, Gabriele ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ISOLATION; CELL LABELING; CELL MIGRATION; CELL SIZE; CELL THERAPY; CELL TRACKING; CELLULAR DISTRIBUTION; EXOSOME; HUMAN; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TISSUE REGENERATION;

EID: 85003874931     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/5029619     Document Type: Review

References (123)

1. L. da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, "Mesenchymal stem cells reside in virtually all post-natal organs and tissues, " Journal of Cell Science, vol. 119, no. 11, pp. 2204-2213, 2006.
2. A. I. Caplan, "Mesenchymal stem cells, " Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641-650, 1991.
3. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for CellularTherapy position statement, " Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
4. E. M. Horwitz, K. Le Blanc, M. Dominici et al., "Clarification of the nomenclature for MSC: The International Society for CellularTherapy position statement, " Cytotherapy, vol. 7, no. 5, pp. 393-395, 2005.
5. A. Keating, "Mesenchymal stromal cells: new directions, " Cell Stem Cell, vol. 10, no. 6, pp. 709-716, 2012.
6. J.-F. Stoltz, N. De Isla, Y. P. Li et al., "Stem cells and regenerative medicine: myth or reality of the 21th century, " Stem Cells International, vol. 2015, Article ID 734731, 19 pages, 2015.
7. L. da Silva Meirelles, A. M. Fontes, D. T. Covas, and A. I. Caplan, "Mechanisms involved in the therapeutic properties of mesenchymal stem cells, " Cytokine and Growth Factor Reviews, vol. 20, no. 5-6, pp. 419-427, 2009.
8. P. Semedo, M. Burgos-Silva, C. Donizetti-Oliveira, and N. O. S. Camara, "How do mesenchymal stem cells repair" in Stem Cells in Clinic and Research, A. Gholamrezanezhad, Ed., chapter 4, pp. 83-104, InTech, Rijeka, Croatia, 2011.
9. T. Wu, Y. Liu, B. Wang, and G. Li, "The roles of mesenchymal stem cells in tissue repair and disease modification, " Current Stem Cell Research andTherapy, vol. 9, no. 5, pp. 424-431, 2014.
10. M. Gnecchi, P. Danieli, G. Malpasso, and M. C. Ciuffreda, "Paracrine mechanisms of mesenchymal stem cells in tissue repair, " in Mesenchymal Stem Cells: Methods and Protocols, M. Gnecchi, Ed., vol. 1416 ofMethods inMolecular Biology, pp. 123-146, Springer, Berlin, Germany, 2016.
11. X. Liang, Y. Ding, Y. Zhang, H.-F. Tse, and Q. Lian, "Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives, " Cell Transplantation, vol. 23, no. 9, pp. 1045-1059, 2014.
12. C. P. Hodgkinson, A. Bareja, J. A. Gomez, and V. J. Dzau, "Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology, " Circulation Research, vol. 118, no. 1, pp. 95-107, 2016.
13. T. J. Burdon, A. Paul, N. Noiseux, S. Prakash, and D. Shum-Tim, "Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential, " Bone Marrow Research, vol. 2011, Article ID 207326, 14 pages, 2011.
14. V. B. R. Konala, M. K. Mamidi, R. Bhonde, A. K. Das, R. Pochampally, and R. Pal, "The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cellfree regeneration, " Cytotherapy, vol. 18, no. 1, pp. 13-24, 2016.
15. T. Katsuda and T. Ochiya, "Molecular signatures of mesenchymal stem cell-derived extracellular vesicle-mediated tissue repair, " Stem Cell Research andTherapy, vol. 6, no. 1, article 214, 2015.
16. C. Tran and M. S. Damaser, "Stem cells as drug delivery methods: application of stem cell secretome for regeneration, " Advanced Drug Delivery Reviews, vol. 82-83, pp. 1-11, 2015.
17. H. Kupcova Skalnikova, "Proteomic techniques for characterisation of mesenchymal stem cell secretome, " Biochimie, vol. 95, no. 12, pp. 2196-2211, 2013.
18. M. Makridakis, M. G. Roubelakis, and A. Vlahou, "Stem cells: insights into the secretome, " Biochimica et Biophysica Acta, vol. 1834, no. 11, pp. 2380-2384, 2013.
19. J. R. Lavoie and M. Rosu-Myles, "Uncovering the secretes of mesenchymal stem cells, " Biochimie, vol. 95, no. 12, pp. 2212-2221, 2013.
20. G. Raposo andW. Stoorvogel, "Extracellular vesicles: exosomes, microvesicles, and friends, " Journal of Cell Biology, vol. 200, no. 4, pp. 373-383, 2013.
21. M. Yáñez-Mó, P. R. Siljander, Z. Andreu et al., "Biological properties of extracellular vesicles and their physiological functions, " Journal of Extracellular Vesicles, vol. 4, Article ID27066, 2015.
22. H. Kalra, G. P. C. Drummen, and S. Mathivanan, "Focus on extracellular vesicles: introducing the next small big thing, " International Journal of Molecular Sciences, vol. 17, no. 2, article 170, 2016.
23. E. van der Pol, A. N. Böing, P. Harrison, A. Sturk, and R. Nieuwland, "Classification, functions, and clinical relevance of extracellular vesicles, " Pharmacological Reviews, vol. 64, no. 3, pp. 676-705, 2012.
24. R. Xu, D. W. Greening, H.-J. Zhu, N. Takahashi, and R. J. Simpson, "Extracellular vesicle isolation and characterization: toward clinical application, "The Journal of Clinical Investigation, vol. 126, pp. 1152-1162, 2016.
25. E. van der Pol, A. G. Hoekstra, A. Sturk, C. Otto, T. G. van Leeuwen, and R. Nieuwland, "Optical and non-opticalmethods for detection and characterization of microparticles and exosomes, " Journal of Thrombosis and Haemostasis, vol. 8, no. 12, pp. 2596-2607, 2010.
26. D. L. Rupert, V. Claudio, C. Lässer, and M. Bally, "Methods for the physical characterization and quantification of extracellular vesicles in biological samples, " Biochimica et Biophysica Acta (BBA)-General Subjects, 2016.
27. F. Momen-Heravi, L. Balaj, S. Alian et al., "Currentmethods for the isolation of extracellular vesicles, " Biological Chemistry, vol. 394, no. 10, pp. 1253-1262, 2013.
28. C. Théry, S. Amigorena, G. Raposo, and A. Clayton, "Isolation andcharacterizationof exosomes fromcell culture supernatants and biological fluids, " in Current Protocols in Cell Biology, chapter 3, unit 3. 22, John Wiley & Sons, New York, NY, USA, 2006.
29. R. Szatanek, J. Baran, M. Siedlar, and M. Baj-Krzyworzeka, "Isolation of extracellular vesicles: determining the correct approach, " International Journal of Molecular Medicine, vol. 36, no. 1, pp. 11-17, 2015.
30. J. Lötvall, A. F. Hill, F. Hochberg et al., "Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles, " Journal of Extracellular Vesicles, vol. 3, Article ID 26913, 2014.
31. E. Willms, H. J. Johansson, I. Mäger et al., "Cells release subpopulations of exosomes with distinctmolecular and biological properties, " Scientific Reports, vol. 6, Article ID22519, 2016.
32. M. Colombo, G. Raposo, and C. Théry, "Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, " Annual Review of Cell and Developmental Biology, vol. 30, pp. 255-289, 2014.
33. S. El Andaloussi, I. Mäger, X. O. Breakefield, and M. J. A. Wood, "Extracellular vesicles: biology and emerging therapeutic opportunities, " Nature Reviews Drug Discovery, vol. 12, no. 5, pp. 347-357, 2013.
34. S. J. Gould andG. Raposo, "Aswewait: copingwith an imperfect nomenclature for extracellular vesicles, " Journal of Extracellular Vesicles, vol. 2, Article ID20389, 2013.
35. J. R. Edgar, "Q&A: what are exosomes, exactly" BMC Biology, vol. 14, article 46, 2016.
36. J. Lin, J. Li, B. Huang et al., "Exosomes: novel biomarkers for clinical diagnosis, " ScientificWorld Journal, vol. 2015, Article ID 657086, 8 pages, 2015.
37. S. W. Ferguson and J. Nguyen, "Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity, " Journal of Controlled Release, vol. 228, pp. 179-190, 2016.
38. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, " Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
39. M. Z. Ratajczak and J. Ratajczak, "Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years later, " Clinical and Translational Medicine, vol. 5, article 7, 2016.
40. M. Eldh, K. Ekström, H. Valadi et al., "Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA, " PLoS ONE, vol. 5, no. 12, Article ID e15353, 2010.
41. S.-I. Ohno, G. P. C. Drummen, and M. Kuroda, "Focus on extracellular vesicles: development of extracellular vesiclebased therapeutic systems, " International Journal of Molecular Sciences, vol. 17, no. 2, p. 172, 2016.
42. B. György, M. E. Hung, X. O. Breakefield, and J. N. Leonard, "Therapeutic applications of extracellular vesicles: clinical promise and open questions, " Annual Review of Pharmacology and Toxicology, vol. 55, pp. 439-464, 2015.
43. N. Tominaga, Y. Yoshioka, and T. Ochiya, "A novel platform for cancer therapy using extracellular vesicles, " Advanced Drug Delivery Reviews, vol. 95, pp. 50-55, 2015.
44. A. Jarmalavici. ute and A. Pivori. unas, "Exosomes as a potential novel therapeutic tools against neurodegenerative diseases, " Pharmacological Research, 2016.
45. O. G. de Jong, B. W. M. van Balkom, R. M. Schiffelers, C. V. C. Bouten, and M. C. Verhaar, "Extracellular vesicles: potential roles in regenerative medicine, " Frontiers in Immunology, vol. 5, article 608, 2014.
46. G. Natasha, B. Gundogan, A. Tan et al., "Exosomes as immunotheranostic nanoparticles, " Clinical Therapeutics, vol. 36, no. 6, pp. 820-829, 2014.
47. L. Biancone, S. Bruno, M. C. Deregibus, C. Tetta, and G. Camussi, "Therapeutic potential of mesenchymal stem cellderived microvesicles, " Nephrology Dialysis Transplantation, vol. 27, no. 8, pp. 3037-3042, 2012.
48. K. Yao and S. D. Ricardo, "Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease, " Nephrology, vol. 21, no. 5, pp. 363-371, 2016.
49. C. Gallina, V. Turinetto, and C. Giachino, "A new paradigm in cardiac regeneration: the mesenchymal stem cell secretome, " Stem Cells International, vol. 2015, Article ID 765846, 10 pages, 2015.
50. T. Lener, M. Gimona, L. Aigner et al., "Applying extracellular vesicles based therapeutics in clinical trials-an ISEV position paper, " Journal of ExtracellularVesicles, vol. 4, Article ID30087, 2015.
51. A. Fuster-Matanzo, F. Gessler, T. Leonardi, N. Iraci, and S. Pluchino, "Acellular approaches for regenerative medicine: On the verge of clinical trials with extracellular membrane vesicles Extracellular vesicles and regenerative medicine, " Stem Cell Research andTherapy, vol. 6, no. 1, article 227, 2015.
52. K. O. Jung, H. Youn, M. J. Kim et al., "In vivo PET imaging of radiolabeled exosomes from breast cancer cells, " Journal of Nuclear Medicine, vol. 56, p. 11, 2015.
53. Z. Varga, I. Gyurkó, K. Pálóczi et al., "Radiolabeling of extracellular vesicles with (99m)Tc for quantitative in vivo imaging studies, " Cancer Biother Radiopharm, vol. 31, no. 5, pp. 168-173, 2016.
54. D. W. Hwang, H. Choi, S. C. Jang et al., "Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using 99m Tc-HMPAO, " Scientific Reports, vol. 5, article 15636, 2015.
55. M. Morishita, Y. Takahashi, M. Nishikawa et al., "Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and Iodine-125-labeled biotin derivative after intravenous injection in mice, " Journal of Pharmaceutical Sciences, vol. 104, no. 2, pp. 705-713, 2015.
56. L. Hu, S. A. Wickline, and J. L. Hood, "Magnetic resonance imaging of melanoma exosomes in lymph nodes, " Magnetic Resonance in Medicine, vol. 74, no. 1, pp. 266-271, 2015.
57. D. Sun, X. Zhuang, X. Xiang et al., "A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes, "MolecularTherapy, vol. 18, no. 9, pp. 1606-1614, 2010.
58. O. P. Wiklander, J. Z. Nordin, A. O'Loughlin et al., "Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting, " Journal of Extracellular Vesicles, vol. 4, Article ID26316, 2015.
59. C. Grange, M. Tapparo, S. Bruno et al., "Biodistribution of mesenchymal stemcell-derived extracellular vesicles in amodel of acute kidney injury monitored by optical imaging, " International Journal of Molecular Medicine, vol. 33, no. 5, pp. 1055-1063, 2014.
60. S.-I. Ohno, M. Takanashi, K. Sudo et al., "Systemically injected exosomes targeted to EGFR deliver antitumor microrna to breast cancer cells, " Molecular Therapy, vol. 21, no. 1, pp. 185-191, 2013.
61. T. Smyth, M. Kullberg, N. Malik, P. Smith-Jones, M. W. Graner, and T. J. Anchordoquy, "Biodistribution and delivery efficiency of unmodified tumor-derived exosomes, " Journal of Controlled Release, vol. 199, pp. 145-155, 2015.
62. Y. Takahashi, M. Nishikawa, H. Shinotsuka et al., "Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection, " Journal of Biotechnology, vol. 165, no. 2, pp. 77-84, 2013.
63. T. Imai, Y. Takahashi, M. Nishikawa et al., "Macrophagedependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice, " Journal of Extracellular Vesicles, vol. 4, article 26238, 2015.
64. C. P. Lai, O. Mardini, M. Ericsson et al., "Dynamic biodistribution of extracellular vesicles in vivo using amultimodal imaging reporter, " ACS Nano, vol. 8, no. 1, pp. 483-494, 2014.
65. A. Suetsugu, K. Honma, S. Saji, H. Moriwaki, T. Ochiya, and R. M. Hoffman, "Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models, " Advanced Drug Delivery Reviews, vol. 65, no. 3, pp. 383-390, 2013.
66. A. Zomer, C. Maynard, F. J. Verweij et al., "In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior, " Cell, vol. 161, no. 5, pp. 1046-1057, 2015.
67. C. P. Lai, E. Y. Kim, C. E. Badr et al., "Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters, " Nature Communications, vol. 6, article 7029, 2015.
68. I. S. Zeelenberg, M. Ostrowski, S. Krumeich et al., "Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses, " Cancer Research, vol. 68, no. 4, pp. 1228-1235, 2008.
69. Z. C. Hartman, J. Wei, O. K. Glass et al., "Increasing vaccine potency through exosome antigen targeting, " Vaccine, vol. 29, no. 50, pp. 9361-9367, 2011.
70. L. Alvarez-Erviti, Y. Seow, H. Yin, C. Betts, S. Lakhal, and M. J. A. Wood, "Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, " Nature Biotechnology, vol. 29, no. 4, pp. 341-345, 2011.
71. Y. Liu, D. Li, Z. Liu et al., "Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse, " Scientific Reports, vol. 5, Article ID17543, 2015.
72. J. M. Cooper, P. B. O. Wiklander, J. Z. Nordin et al., "Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice, " Movement Disorders, vol. 29, no. 12, pp. 1476-1485, 2014.
73. R. Ruiss, S. Jochum, R. Mocikat, W. Hammerschmidt, and R. Zeidler, "EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells-a newoption for the treatment of B-CLL, " PLoSONE, vol. 6, no. 10, Article ID e25294, 2011.
74. Y. Tian, S. Li, J. Song et al., "A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy, " Biomaterials, vol. 35, no. 7, pp. 2383-2390, 2014.
75. A. K. A. Silva, N. Luciani, F. Gazeau et al., "Combiningmagnetic nanoparticles with cell derived microvesicles for drug loading and targeting, " Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 11, no. 3, pp. 645-655, 2015.
76. S. A. Kooijmans, C. G. Aleza, S. R. Roffler, W. W. van Solinge, P. Vader, and R. M. Schiffelers, "Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting, " Journal of Extracellular Vesicles, vol. 5, no. 0, 2016.
77. S. A. A. Kooijmans, L. A. L. Fliervoet, R. Van Der Meel et al., "PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time, " Journal of Controlled Release, vol. 224, pp. 77-85, 2016.
78. D. Koppers-Lalic, M. M. Hogenboom, J. M. Middeldorp, and D. M. Pegtel, "Virus-modified exosomes for targeted RNA delivery; A new approach in nanomedicine, " Advanced Drug Delivery Reviews, vol. 65, no. 3, pp. 348-356, 2013.
79. Y. T. Sato, K. Umezaki, S. Sawada et al., "Engineering hybrid exosomes by membrane fusion with liposomes, " Scientific Reports, vol. 6, article 21933, 2016.
80. J. Lee, H. Lee, U. Goh et al., "Cellular engineering with membrane fusogenic liposomes to produce functionalized extracellular vesicles, " ACS Applied Materials & Interfaces, vol. 8, no. 11, pp. 6790-6795, 2016.
81. M. Wang, S. Altinoglu, Y. S. Takeda, and Q. Xu, "Integrating protein engineering and bioorthogonal click conjugation for extracellular vesicle modulation and intracellular delivery, " PLoS ONE, vol. 10, no. 11, article e0141860, 2015.
82. T. Smyth, K. Petrova, N. M. Payton et al., "Surface functionalization of exosomes using click chemistry, " Bioconjugate Chemistry, vol. 25, no. 10, pp. 1777-1784, 2014.
83. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., "Pluripotency ofmesenchymal stemcells derived from adultmarrow, " Nature, vol. 418, no. 6893, pp. 41-49, 2002.
84. A. Trivisonno, M. Abecassis, M. Monti, G. Toietta, and A. Bachir, "Adipose tissue: from energy reservoir to a source of cells for epithelial tissue engineering, " in Stem Cells in Aesthetic Procedures, M. A. Shiffman, A. Di Giuseppe, and F. Bassetto, Eds., pp. 303-326, Springer, Berlin, Germany, 2014.
85. S. E. Haynesworth, M. A. Baber, and A. I. Caplan, "Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1, " Journal of Cellular Physiology, vol. 166, no. 3, pp. 585-592, 1996.
86. G. Camussi, M. C. Deregibus, and V. Cantaluppi, "Role of stemcell-derived microvesicles in the paracrine action of stem cells, " Biochemical Society Transactions, vol. 41, no. 1, pp. 283-287, 2013.
87. R. M. Johnstone, M. Adam, J. R. Hammond, L. Orr, and C. Turbide, "Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes), " Journal of Biological Chemistry, vol. 262, no. 19, pp. 9412-9420, 1987.
88. S. Bruno, C. Grange, M. C. Deregibus et al., "Mesenchymal stem cell-derived microvesicles protect against acute tubular injury, " Journal of theAmerican Society of Nephrology, vol. 20, no. 5, pp. 1053-1067, 2009.
89. T. Li, Y. Yan, B. Wang et al., "Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis, " Stem Cells and Development, vol. 22, no. 6, pp. 845-854, 2013.
90. R. C. Lai, F. Arslan, M. M. Lee et al., "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury, " Stem Cell Research, vol. 4, no. 3, pp. 214-222, 2010.
91. A. Marote, F. G. Teixeira, B. Mendes-Pinheiro, and A. J. Salgado, "MSCs-derived exosomes: cell-secreted nanovesicles with regenerative potential, " Frontiers in Pharmacology, vol. 7, article 231, 2016.
92. C. Tetta, S. Bruno, V. Fonsato, M. C. Deregibus, and G. Camussi, "The role of microvesicles in tissue repair, " Organogenesis, vol. 7, no. 2, pp. 105-115, 2011.
93. J. Stephen, E. L. Bravo, D. Colligan, A. R. Fraser, J. Petrik, and J. D. M. Campbell, "Mesenchymal stromal cells asmultifunctional cellular therapeutics-a potential role for extracellular vesicles, " Transfusion and Apheresis Science, vol. 55, no. 1, pp. 62-69, 2016.
94. S. Rani, A. E. Ryan, M. D. Griffin, and T. Ritter, "Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications, " Molecular Therapy, vol. 23, no. 5, pp. 812-823, 2015.
95. T. S. Chen, F. Arslan, Y. Yin et al., "Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs, " Journal of Translational Medicine, vol. 9, article 47, 2011.
96. R. W. Y. Yeo, R. C. Lai, B. Zhang et al., "Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery, " Advanced Drug Delivery Reviews, vol. 65, no. 3, pp. 336-341, 2013.
97. S. Rana, S. Yue, D. Stadel, and M. Zöller, "Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection, " International Journal of Biochemistry and Cell Biology, vol. 44, no. 9, pp. 1574-1584, 2012.
98. V. Sokolova, A.-K. Ludwig, S. Hornung et al., "Characterisation of exosomes derived fromhuman cells by nanoparticle tracking analysis and scanning electron microscopy, " Colloids and Surfaces B: Biointerfaces, vol. 87, no. 1, pp. 146-150, 2011.
99. C. Akyurekli, Y. Le, R. B. Richardson, D. Fergusson, J. Tay, and D. S. Allan, "A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles, " Stem Cell Reviews and Reports, vol. 11, no. 1, pp. 150-160, 2015.
100. H. Choi and D. S. Lee, "Illuminating the physiology of extracellular vesicles, " Stem Cell Research & Therapy, vol. 7, article 55, 2016.
101. A. J. Ullal, D. S. Pisetsky, and C. F. Reich III, "Use of SYTO 13, a fluorescent dye binding nucleic acids, for the detection of microparticles in in vitro systems, " Cytometry Part A, vol. 77, no. 3, pp. 294-301, 2010.
102. T. Tian, Y. Wang, H. Wang, Z. Zhu, and Z. Xiao, "Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy, " Journal of Cellular Biochemistry, vol. 111, no. 2, pp. 488-496, 2010.
103. K. Laulagnier, H. Vincent-Schneider, S. Hamdi, C. Subra, D. Lankar, and M. Record, "Characterization of exosome subpopulations fromRBL-2H3 cells using fluorescent lipids, " Blood Cells, Molecules, and Diseases, vol. 35, no. 2, pp. 116-121, 2005.
104. E. J. van der Vlist, E. N. M. Nolte-'t Hoen, W. Stoorvogel, G. J. A. Arkesteijn, and M. H. M. Wauben, "Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry, " Nature Protocols, vol. 7, no. 7, pp. 1311-1326, 2012.
105. S. Bala, T. Csak, F. Momen-Heravi et al., "Biodistribution and function of extracellular miRNA-155 in mice, " Scientific Reports, vol. 5, article 10721, 2015.
106. D. Shcherbo, E. M. Merzlyak, T. V. Chepurnykh et al., "Bright far-red fluorescent protein for whole-body imaging, " Nature Methods, vol. 4, no. 9, pp. 741-746, 2007.
107. J. E. Kim, S. Kalimuthu, and B.-C. Ahn, "In vivo cell tracking with bioluminescence imaging, " Nuclear Medicine and Molecular Imaging, vol. 49, no. 1, pp. 3-10, 2015.
108. G. Di Rocco, A. Gentile, A. Antonini et al., "Analysis of biodistribution and engraftment into the liver of genetically modified mesenchymal stromal cells derived from adipose tissue, " Cell Transplantation, vol. 21, no. 9, pp. 1997-2008, 2012.
109. R. C. Lai, S. S. Tan, R. W. Yeo et al., "MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein andRNA, " Journal of ExtracellularVesicles, vol. 5, Article ID 29828, 2016.
110. R. van der Meel, M. H. A. M. Fens, P. Vader, W. W. Van Solinge, O. Eniola-Adefeso, and R. M. Schiffelers, "Extracellular vesicles as drug delivery systems: lessons from the liposome field, " Journal of Controlled Release, vol. 195, pp. 72-85, 2014.
111. R. Linares, S. Tan, C. Gounou, N. Arraud, and A. R. Brisson, "High-speed centrifugation induces aggregation of extracellular vesicles, " Journal of Extracellular Vesicles, vol. 4, article 29509, 2015.
112. B. György, K. Módos, é. Pállinger et al., "Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters, " Blood, vol. 117, no. 4, pp. e39-e48, 2011.
113. O. Moreno-Gonzalo, C. Villarroya-Beltri, and F. Sánchez-Madrid, "Post-translational modifications of exosomal proteins, " Frontiers in Immunology, vol. 5, article 383, 2014.
114. L. A. Mulcahy, R. C. Pink, and D. R. Carter, "Routes and mechanisms of extracellular vesicle uptake, " Journal of Extracellular Vesicles, vol. 3, Article ID24641, 2014.
115. D. Feng, W.-L. Zhao, Y.-Y. Ye et al., "Cellular internalization of exosomes occurs through phagocytosis, " Traffic, vol. 11, no. 5, pp. 675-687, 2010.
116. D. Ha, N. Yang, and V. Nadithe, "Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges, " Acta Pharmaceutica Sinica B, vol. 6, no. 4, pp. 287-296, 2016.
117. A. R. Hajrasouliha, G. Jiang, Q. Lu et al., "Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization, " Journal of Biological Chemistry, vol. 288, no. 39, pp. 28058-28067, 2013.
118. H. M. van Dongen, N. Masoumi, K. W. Witwer, and D. M. Pegtel, "Extracellular vesicles exploit viral entry routes for cargo delivery, " Microbiology and Molecular Biology Reviews, vol. 80, no. 2, pp. 369-386, 2016.
119. M. Kotmakç and V. B. çetintaş, "Extracellular vesicles as natural nanosized delivery systems for small-molecule drugs and genetic material: steps towards the future nanomedicines, " Journal of Pharmacy and Pharmaceutical Sciences, vol. 18, no. 3, pp. 396-413, 2015.
120. S. EL Andaloussi, S. Lakhal, I. Mäger, and M. J. A. Wood, "Exosomes for targeted siRNA delivery across biological barriers, " Advanced Drug Delivery Reviews, vol. 65, no. 3, pp. 391-397, 2013.
121. S. A. Kooijmans, R. M. Schiffelers, N. Zarovni, and R. Vago, "Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: newnanotools for cancer treatment, " Pharmacological Research, vol. 111, pp. 487-500, 2016.
122. M. E. Hung and J. N. Leonard, "Stabilization of exosometargeting peptides via engineered glycosylation, " The Journal of Biological Chemistry, vol. 290, no. 13, pp. 8166-8172, 2015.
123. R. P. Garay, R. El-Gewely, J. K. Armstrong, G. Garratty, and P. Richette, "Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents, " Expert Opinion on Drug Delivery, vol. 9, no. 11, pp. 1319-1323, 2012.